Chondroitin for use in medicine
US10206944B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 22, 2013 |
| Grant date | Feb 19, 2019 |
| Priority date | — |
| Expiry date | Sep 4, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chondroitin, a metabolic intermediate of chondroitin sulphate biosynthesis in mammals and other living organisms, possesses biological properties different from those of chondroitin sulphate, and can be advantageously used for applications in the pharmaceutical, nutraceutical, cosmeceutical and medical device fields. Chondroitin has biostimulating, anti-inflammatory and anti-microbial activity and can be used in the treatment of osteoarthritis, eye disorders, interstitial cystitis, lung disorders, inflammatory disorders in general, oncological disorders, peritoneal dialysis, tissue biorevitalisation and wound repair, as a skin filler, and as bioresorbable scaffolds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.